Momelotinib-d4

SL-9664

Momelotinib-d₄, >98%

Related CAS No. : [1056634-68-4] of the unlabelled compound

Synonyms : CYT-387-d₄

IUPAC Name : N-(Cyanomethyl)-4-(2-((4-morpholinophenyl-2,3,5,6-d₄)amino)pyrimidin-4-yl)benzamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
25MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
50MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : This is a deuterium labelled version of Momelotinib, which is an inhibitor of JAK1/JAK2. Momelotinib is used for treating myelofibrosis in adults with anemia.

References : Pardanani A. et al.: Leukemia 23(8), 1441-1445, 2009; Monaghan K. A. et al.: Leukemia 25(12), 1891-1899, 2011; Tyner J. W. et al.: Blood 115(25), 5232-5240,2010; Kitajima S. et al.: Cancer Cell 34(3), 439-452, 2018.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.